The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiolJ.M. Ignacio Lopez-Mendez, Alejandro Zentella‐Dehesa|Oncology Letters|2023Cited by 2